When people with irritable bowel syndrome (IBS) were asked to relate their mood to a color, those choosing a positive color were nine times more likely to respond to hypnotherapy than those who chose a negative color or no color at all. Researchers writing in the open access journal BMC Complementary and Alternative Medicine suggest that these findings could be used to predict responders to treatment.
Peter Whorwell worked with a team of researchers from the University of Manchester, UK, to carry out the study using a color chart called the 'Manchester Color Wheel' which allows patients to choose colors that have previously been defined as positive, neutral or negative. He said, "Our unit has been providing hypnotherapy for the treatment of IBS for over twenty years with approximately two thirds of patients responding to treatment. Unfortunately, patients may require as many as twelve one hour sessions of therapy to secure a response and therefore this results in the treatment being relatively expensive to provide. Consequently it would be very useful to be able to predict responders".
Speaking about the results Whorwell said, "Being able to describe mood in terms of a positive color is a sign of an active imagination, which is an important component of hypnotic ability". The hypnotherapy provided in Professor Whorwell's Unit is called gut-focused hypnotherapy. The technique aims to give a patient control over their gut and they have shown that following a course of treatment actual changes in gastrointestinal function can be demonstrated.
Notes to Editors
1. Mood color choice helps to predict response to hypnotherapy in patients with irritable bowel syndrome
Helen R Carruthers, Julie Morris, Nicholas Tarrier and Peter J Whorwell
BMC Complementary and Alternative Medicine (in press)
During embargo, article available here: http://www.biomedcentral.com/imedia/1447918692394950_article.pdf?random=208845
After the embargo, article available at the journal website: http://www.biomedcentral.com/bmccomplementalternmed/
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.
Article citation and URL available on request at firstname.lastname@example.org on the day of publication.
2. BMC Complementary and Alternative Medicine is an open access journal publishing original peer-reviewed research articles in interventions and resources that complement or replace conventional therapies, with a specific emphasis on research that explores the biological mechanisms of action, as well as their efficacy, safety, costs, patterns of use and/or implementation. BMC Complementary and Alternative Medicine (ISSN 1472-6882) is indexed/tracked/covered by PubMed, MEDLINE, CAS, EMBASE, Scopus, Cinahl, FSTA, CABI, Thomson Reuters (ISI) and Google Scholar.
3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.